Sophie Molet
Impact in
- Immunology and Allergy top 1%
- Allergic Rhinitis and Sensitization
- Immunology top 1%
- IL-33, ST2, and ILC Pathways
- Psoriasis: Treatment and Pathogenesis
- Inflammation biomarkers and pathways
Papers in
-
- Allergic Rhinitis and Sensitization 6
- Physiology 17
- Asthma and respiratory diseases 16
- Co-authors
- Qutayba HamidJack A. EliasJamila ChakirRon OlivensteinEsra NutkuNathalie PagéMichel LavioletteLouis‐Philippe Boulet
- Journals
- Journal of Allergy and Clinical Immunology (9 papers)American Journal of Respiratory and Critical Care Medicine (2 papers)Blood (2 papers)Inflammation Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- CanadaFranceUnited States
In The Last Decade
Sophie Molet
25 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Immunology and Allergy 578
- Immunology 1.6k
- Physiology 1.6k
- Dermatology 368
- Emergency Medical Services 255
Countries citing papers authored by Sophie Molet
This map shows the geographic impact of Sophie Molet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Molet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Molet more than expected).
Fields of papers citing papers by Sophie Molet
This network shows the impact of papers produced by Sophie Molet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Molet. The network helps show where Sophie Molet may publish in the future.
Co-authors
The 25 scholars most cited alongside Sophie Molet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 192 | |
| 2 | 2003 | 247 | |
| 3 | 2003 | 81 | |
| 4 | Airway remodeling-associated mediators in moderate to severe asthma: Effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression Hit paper breakdown → | 2003 | 549 |
| 5 | 2002 | 34 | |
| 6 | 2002 | 42 | |
| 7 | 2001 | 11 | |
| 8 | 2001 | 114 | |
| 9 | IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines Hit paper breakdown → | 2001 | 768 |
| 10 | 2000 | 117 | |
| 11 | 2000 | 50 | |
| 12 | 1999 | 159 | |
| 13 | 1999 | 60 | |
| 14 | 1999 | 29 | |
| 15 | 1999 | 125 | |
| 16 | 1998 | 8 | |
| 17 | 1998 | 18 | |
| 18 | 1996 | 32 | |
| 19 | 1996 | 307 | |
| 20 | 1994 | 11 |
About Sophie Molet
Sophie Molet is a scholar working on Immunology and Allergy, Physiology, Immunology, Otorhinolaryngology and Rheumatology, having authored 25 papers that have together received 3.2k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (16 papers), Allergic Rhinitis and Sensitization (6 papers), Mast cells and histamine (5 papers), IL-33, ST2, and ILC Pathways (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Pulmonary Hypertension Research and Treatments (3 papers), Eosinophilic Esophagitis (3 papers) and Urticaria and Related Conditions (2 papers). The work is most often cited by research in Immunology and Allergy (578 citations), Immunology (1.6k citations), Physiology (1.6k citations), Dermatology (368 citations) and Emergency Medical Services (255 citations). Sophie Molet has collaborated with scholars based in Canada, France and United States. Frequent co-authors include Qutayba Hamid, Jack A. Elias, Jamila Chakir, Qutayba Hamid, Ron Olivenstein, Esra Nutku, Nathalie Pagé, Michel Laviolette, Louis‐Philippe Boulet and Motonori Fukakusa. Their work appears in journals such as Journal of Allergy and Clinical Immunology, American Journal of Respiratory and Critical Care Medicine, Blood, Inflammation Research and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.